Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haifeng Tang

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Computational Biology and Chemistry|August 17, 2025
A novel network for resolving subjective masking differences and accurate thyroid nodule diagnosisZhiyuan Ouyang, Simei Huang, Liuju Liang, et al.
Plant Biotechnology Journal|July 1, 2023
A high-efficiency gene silencing in plants using two-hit asymmetrical artificial MicroRNAsSachin Teotia, Xiaoran Wang, Na Zhou, et al.
Assay and Drug Development Technologies|August 14, 2012
The inwardly rectifying potassium channel Kir1.1: development of functional assays to identify and characterize channel inhibitorsJohn P Felix, Birgit T Priest, Kelli Solly, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2013
Pharmacologic inhibition of the renal outer medullary potassium channel causes diuresis and natriuresis in the absence of kaliuresisMaria L Garcia, Birgit T Priest, Magdalena Alonso-Galicia, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2010
Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activitiesHaifeng Tang, Yan Yan, Zhe Feng, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2017
The design and synthesis of novel spirocyclic heterocyclic sulfone ROMK inhibitors as diureticsHarry R Chobanian, Yan Guo, Barbara Pio, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism DiureticsHaifeng Tang, Shawn P Walsh, Yan Yan, et al.
Journal of Medicinal Chemistry|October 13, 2025
Accelerated <i>In Silico</i> Discovery of <b>SGR-1505</b>: A Potent MALT1 Allosteric Inhibitor for the Treatment of Mature B-Cell MalignanciesZhe Nie, Michael Trzoss, Andrew T Placzek, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2016
The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II PhenotypeCaryn Hampton, Xiaoyan Zhou, Birgit T Priest, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl)ethyl)isobenzofuran-1(3H)-oneHaifeng Tang, Reynald K de Jesus, Shawn P Walsh, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Computational Biology and Chemistry|August 17, 2025
A novel network for resolving subjective masking differences and accurate thyroid nodule diagnosisZhiyuan Ouyang, Simei Huang, Liuju Liang, et al.
Plant Biotechnology Journal|July 1, 2023
A high-efficiency gene silencing in plants using two-hit asymmetrical artificial MicroRNAsSachin Teotia, Xiaoran Wang, Na Zhou, et al.
Assay and Drug Development Technologies|August 14, 2012
The inwardly rectifying potassium channel Kir1.1: development of functional assays to identify and characterize channel inhibitorsJohn P Felix, Birgit T Priest, Kelli Solly, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2013
Pharmacologic inhibition of the renal outer medullary potassium channel causes diuresis and natriuresis in the absence of kaliuresisMaria L Garcia, Birgit T Priest, Magdalena Alonso-Galicia, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2010
Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activitiesHaifeng Tang, Yan Yan, Zhe Feng, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2017
The design and synthesis of novel spirocyclic heterocyclic sulfone ROMK inhibitors as diureticsHarry R Chobanian, Yan Guo, Barbara Pio, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism DiureticsHaifeng Tang, Shawn P Walsh, Yan Yan, et al.
Journal of Medicinal Chemistry|October 13, 2025
Accelerated <i>In Silico</i> Discovery of <b>SGR-1505</b>: A Potent MALT1 Allosteric Inhibitor for the Treatment of Mature B-Cell MalignanciesZhe Nie, Michael Trzoss, Andrew T Placzek, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2016
The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II PhenotypeCaryn Hampton, Xiaoyan Zhou, Birgit T Priest, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl)ethyl)isobenzofuran-1(3H)-oneHaifeng Tang, Reynald K de Jesus, Shawn P Walsh, et al.
Pageof 14